Overview
Status
Active
Registry date
2021-04-30
Share capital
5,000.00 PLN
Registered address
ul. Złota 7/1, 00-019 Warszawa, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
2 of 5 financial statements were filed late (the longest delay 711 days for 2022).
- 2025filed
- 202425/06/2025
- 202325/06/2025
- 202225/06/2025
- 202128/06/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.38kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -225.72MedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 3.30kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 20.73kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Paweł Marek Mirosz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Erik Charles Bobellaage 50 | 30 | $405.19 | 30% |
Hubert Limaninage 43 | 10 | $135.06 | 10% |
Paweł Marek Miroszage 47 | 30 | $405.19 | 30% |
Artur Molgaage 47 | 30 | $405.19 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-12-04.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-04-27 | Address change (Ul. Jana Kazimierza 23/39, 01-248, Warszawa → Ul. Złota 7/1, 00-019, Warszawa) | |
| 2021-04-30 | Entered in the register |
FAQ
The main business activity of Aqulus focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on April 30, 2021.
The headquarters is located at: ul. Złota 7, 00-019 Warszawa.
The management board consists of: Paweł Marek Mirosz (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $860, representing a decrease of 98.5% compared to 2023.
No, the company recorded a net loss of $52 in 2024.
The largest operating cost category falls under external services. This category amounted to $333 in 2024, representing 63% of all operating expenses.
Last updated: 2026-04-26
